Merrimack Pharmaceuticals Inc

Merrimack is a biopharmaceutical company that focuses on discovering and developing medicines for the treatment of cancer.

Business Model:

Revenue: $25.9M

Employees: 11-50

Rankings

Detailed Merrimack Pharmaceuticals Inc Information

Geographic Data

Merrimack Pharmaceuticals Inc headquarters map

Address: One Broadway

City: Cambridge

State: MA

Zip: 02142

Country: US

Financial Info

Stage:

post ipo debt

Raised Last:

$25M

Raised Total:

$288M

Metrics

2,024,871Website Global Rank

10,204Website Monthly Traffic

Twitter Followers

Description

Merrimack is a biopharmaceutical company that focuses on discovering and developing medicines for the treatment of cancer.

Contact Phone:
+16174411000

Contact Email:

Merrimack Pharmaceuticals Inc went public on 3/29/2012 on the NASDAQ

Listed Exchange:
NASDAQ

IPO Date:
3/29/2012

Ticker Symbol:
MACK

IPO Price:
$7/share

Amount Raised:
$100M

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
Announced Date Transaction Number of Investors Money Raised Lead Investors
7/2018 Debt $15M Hercules Capital
12/2007 Series F $35M Jennison Associates LLC
3/2012 IPO $100.1M
11/2010 Grant $2.4M
6/2005 Debt Financing 1 $9M Hercules Capital
Hercules Capital
4/2011 Private Equity Round $0 TPG-Axon Capital
Credit Suisse
Jennison Associates
WT Investment Advisors Fund
Crocker Ventures
TPG-Axon Capital
Credit Suisse
Jennison Associates
WT Investment Advisors Fund
Crocker Ventures
4/2006 Series E $0 Sorenson Development
Jennison Associates
TPG-Axon Capital
WT Investment Advisors Fund
Sorenson Development
Jennison Associates
TPG-Axon Capital
WT Investment Advisors Fund
4/2005 Series D 3 $28.3M WT Investment Advisors Fund
Unilever Ventures
Sorenson Development
12/2003 Series C $18.3M
1/2002 Series B 1 - Expansion Venture Capital
Expansion Venture Capital
3/2004 Grant 1 - National Institutes of Health
National Institutes of Health
5/2004 Series C $0 Sorenson Development
GTC Biotherapeutics
Wharton Capital
Sorenson Development
GTC Biotherapeutics
Wharton Capital
11/2007 Series F $35M
7/2018 Post-IPO Debt 1 $25M Hercules Capital
Hercules Capital
Hercules Capital
Hercules Capital
3/2006 Venture Round 1 - University Growth Fund
University Growth Fund
4/2011 Series G 5 $77M Credit Suisse
Crocker Ventures
TPG-Axon Capital
Credit Suisse
Jennison Associates
WT Investment Advisors Fund
Crocker Ventures
4/2006 Series E 4 $65M Sorenson Development
Jennison Associates
TPG-Axon Capital
WT Investment Advisors Fund
Sorenson Development
Jennison Associates
TPG-Axon Capital
WT Investment Advisors Fund
3/2006 Venture Round 1 -
5/2004 Series C 3 $28M Sorenson Development
Sorenson Development
3/2004 Grant 1 - National Institutes of Health
National Institutes of Health
Announced Date Name Price

Employee Departments

Employee States

Uniview Singapore VEID Logo
Uniview Singapore VEID
Revenue: 0 - 100000
Employees:
Industry: Software
Details
Konkuk University Medical Center Logo
Konkuk University Medical Center
Revenue: 0 - 100000
Employees: 51 - 500
Industry: Education
Details
Daemon Technologies Logo
Daemon Technologies
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Blockchain
Details
Ace International Trade Logo
Ace International Trade
Revenue: 0 - 100000
Employees: 11 - 50
Industry: Industrial
Details
An Hòa Communications Logo
An Hòa Communications
Revenue: 0 - 100000
Employees: 1 - 10
Industry: Advertising
Details

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research